Provided by Tiger Fintech (Singapore) Pte. Ltd.

OCUMENSION-B

8.350
+0.4205.30%
Volume:1.40M
Turnover:11.58M
Market Cap:6.81B
PE:-19.48
High:8.400
Open:7.930
Low:7.930
Close:7.930
52wk High:12.230
52wk Low:3.620
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:0.91
T/O Rate:0.17%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.429
ROE:-7.76%
ROA:-5.07%
PB:1.70
PE(LYR):-19.48
PS:11.45

Loading ...

Lupeng Pharmaceuticals Submits IPO Application to HKEX, Core Product LP-168 is the World's First and Only Dual "Covalent and Non-Covalent" BTK Inhibitor

Stock News
·
2 hours ago

ASCLETIS-B (01672) Repurchases 200,000 Shares for HK$1.93 Million on October 31

Stock News
·
Oct 31

Hong Kong Stocks Movement | ASCLETIS-B (01672) Rises Over 4% as Subcutaneous Amylin Receptor Agonist ASC36 Enters Clinical Development

Stock News
·
Oct 31

U.S. Stock Movement | Moderna (MRNA.US) Surges Over 9% Amid Acquisition Talks with Major Pharma

Stock News
·
Oct 30

ASCLETIS-B (01672) Selects Best-in-Class Monthly Subcutaneous Amylin Receptor Agonist ASC36 for Clinical Development

Stock News
·
Oct 30

China's 11th National Drug Procurement Bidding Concludes: 55 Drugs in Fierce Price Competition as New Rules Reshape Industry Logic

Stock News
·
Oct 29

ASCLETIS-B (01672) Repurchased 100,000 Shares for HK$918,900 on October 28

Stock News
·
Oct 28

New Drug Sales Offset Entresto Patent Expiry Impact, Novartis AG (NVS.US) Q3 Operating Profit Rises 6%

Stock News
·
Oct 28

Hong Kong Stock Short Selling Statistics | October 28

Stock News
·
Oct 28

ASCLETIS-B (01672): ASCLETIS to Present Research Findings on ASC30 Oral Tablets, ASC30 Injection, and ASC31 Combined with ASC47 at ObesityWeek® 2025

Stock News
·
Oct 27

Shanghai Pharma's Subsidiary Becomes Holder of Market Authorization for Amisulpride Orally Disintegrating Tablets

Deep News
·
Oct 24

OCUMENSION-B's IPO in Hong Kong: Sudden "Clear-out Dividend" of 320 Million Yuan Directly to Controlling Shareholder's Family, with Illegal Financing Exceeding 400 Million Yuan and Blame Placed on Financial Manager

Deep News
·
Oct 23

ASCLETIS-B (01672) Spends Approximately HKD 926,500 to Repurchase 100,000 Shares on October 22

Stock News
·
Oct 22

ASCLETIS-B (01672) Completes the Enrollment of Asc30, a Monthly Subcutaneous Depot Formulation for Obesity in Phase IIa Study in the U.S.

Stock News
·
Oct 20

US Stocks Movements | Rani Therapeutics (RANI.US) Soars Over 265% After $1.085 Billion Partnership Agreement with Chugai Pharmaceutical

Stock News
·
Oct 17

ASCLETIS-B (01672) Spends HKD 915,250 to Repurchase 100,000 Shares on October 17

Stock News
·
Oct 17

Guangdong Huatie Tongda (000976) Investors Apply for Enforcement in Compensation Case, Hainan Poly Pharm (300630) Files for Claims Again

Deep News
·
Oct 17

Positive Developments for Tiansheng Pharmaceutical Amid Past False Financial Reporting Claims

Deep News
·
Oct 16

ASCLETIS-B (01672) Invests HKD 948,700 to Buy Back 100,000 Shares on October 15

Stock News
·
Oct 15

Zhongjiang Wanxi Pharmaceutical: Village-Enterprise Collaboration Activates Revitalization Momentum

Deep News
·
Oct 15